Tivicay Tablet, Film Coated
Product Images NDC 49702-227

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Tivicay (NDC 49702-227). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viiv Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dolutegravir Chemical Structure (Tivicay Spl Graphic 01)

Chemical structure diagram of dolutegravir sodium, the active ingredient in Tivicay. The structure shows molecular bonds and key functional groups characteristic of dolutegravir sodium.*

FDA Label Image

Tivicay 10 mg 30 Count Label (Tivicay Spl Graphic 02)

An instructional illustration depicting a bottle, measuring cup, and syringe components labeled with parts including bottle, cup, syringe, plunger, and tip for measuring or dispensing liquid medication. The cup shows volume marks from 5 mL to 30 mL, and the syringe has volume markings up to 10 mL.*

FDA Label Image

Tivicay 25 mg Count Label (Tivicay Spl Graphic 03)

An illustrated water volume guide chart showing the number of tablets (ranging from 1 to 6) in relation to water volume (5 mL for 1-3 tablets, 10 mL for 4-6 tablets). Next to the chart, an illustration of a measuring cup marked with volumes from 5 mL to 30 mL is shown with water being poured into it.*

FDA Label Image

Tivicay 50 mg 30 Count Label (Tivicay Spl Graphic 04)

Instructional diagram showing how to swirl a liquid medication in a measuring cup. The left side depicts a hand holding a cup with volume markings from 5 mL to 30 mL. The right side shows swirling motion indicated by an orange arrow in a circular direction for 1 to 2 minutes.*

FDA Label Image

Tivicay Spl Graphic 05

An instructional illustration showing a hand administering oral medication to a child using a small measuring cup or syringe placed near the child's mouth. The image is titled 'Give the medicine to a child.'*

FDA Label Image

Tivicay Spl Graphic 06

Illustration showing the administration of medicine to an infant using a syringe. It depicts filling the syringe from a container and then giving the medicine orally to the infant, emphasizing careful and gentle delivery.*

FDA Label Image

Tivicay Spl Graphic 07

Illustration showing two steps of medication preparation or administration. The left side depicts fingers holding a small tablet with water droplets, suggesting dissolving or wetting the tablet. The right side shows hands holding two syringes, one being inserted into the other, possibly mixing or transferring liquid. No specific product branding visible.*

FDA Label Image

Tivicay Spl Graphic 08

Tivicay PD (dolutegravir) Tablets for Oral Suspension 5 mg label with instructions, warnings, and contents listed. The label specifies non-interchangeability with Tivicay and Tivicay PD, tablet composition, and packaging contents including 1 bottle of 60 tablets, dosing syringe, dosing cup, prescribing info, and instructions for use. ViiV Healthcare logo appears at the top right.*

FDA Label Image

Tivicay Spl Graphic 09

Tivicay 10 mg film-coated tablets packaging label. Contains dolutegravir sodium equivalent to 10 mg dolutegravir per tablet. The bottle contains 30 tablets. Labeler is ViiV Healthcare Company. Storage instructions and manufacturing details by ViiV Healthcare and GlaxoSmithKline are included.*

FDA Label Image

Tivicay Spl Graphic 10

Label for Tivicay (dolutegravir) 25 mg film-coated tablets, oral dosage form. The package contains 30 tablets. The label includes storage instructions, manufacturer information listing ViiV Healthcare Company and GlaxoSmithKline, and the product is made in Japan.*

FDA Label Image

Tivicay Spl Graphic 11

Tivicay 50 mg film-coated tablet label showing the active ingredient dolutegravir sodium equivalent to 50 mg dolutegravir. This prescription drug package contains 30 tablets. The label includes storage instructions, prescribing information note, and identifies ViiV Healthcare and GlaxoSmithKline as the manufacturers, with the product made in Japan.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.